Results 31 to 40 of about 202 (68)

Complement in brain and eye disease: shared mechanisms, convergent pathologies, and common therapeutic opportunities. [PDF]

open access: yesMamm Genome
Nimmo J   +7 more
europepmc   +1 more source

Nucleic acid aptamers: new methods for selection, target validation, molecular diagnostics and therapeutics. [PDF]

open access: yesSignal Transduct Target Ther
Ji DK   +9 more
europepmc   +1 more source

Clinical endpoints special session, ISCEV 2025, Utrecht. [PDF]

open access: yesDoc Ophthalmol
Hamilton R   +9 more
europepmc   +1 more source

Are we there yet with XNA aptamers? [PDF]

open access: yesRSC Adv
Chaillou S   +4 more
europepmc   +1 more source

Aptamers in cancer therapy: Why has clinical translation lagged behind preclinical promise? [PDF]

open access: yesBiomed Pharmacother
Tran TT   +7 more
europepmc   +1 more source

Editorial: Novel therapeutic strategies for retinal degeneration. [PDF]

open access: yesFront Ophthalmol (Lausanne)
Soliño M, López-Costa JJ, Martínez A.
europepmc   +1 more source

Home - About - Disclaimer - Privacy